Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Safety of pneumococcal revaccination

R Rodriguez1, P D Dyer

  • 1Allergy/Immunization Clinic, Fitzsimons Army Medical Center, Aurora, Colorado 80045-5001, USA.

Journal of General Internal Medicine
|September 1, 1995
PubMed
Summary

Pneumococcal polysaccharide revaccination is safe for most patients. Adverse reactions observed were mild and comparable to initial vaccination, suggesting revaccination is a viable option for eligible individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EPI functional MRI: a useful tool for preoperative rolandic fissure localization.

Frontiers of radiation therapy and oncology·1999
Same author

Identification, isolation, and characterization of Ole e 7, a new allergen of olive tree pollen.

The Journal of allergy and clinical immunology·1999
Same author

The spatial properties of a model neuron increase its coding range.

Biological cybernetics·1999
Same author

Reduction aortoplasty: readaptation technique in great vessel mismatches in heart transplantation.

Transplantation proceedings·1999
Same author

Pretransplant risk factors of early mortality after orthotopic heart transplantation.

Transplantation proceedings·1999
Same author

Perioperative mortality risk factors after orthotopic heart transplantation.

Transplantation proceedings·1999

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Pneumococcal polysaccharide vaccine (PPV) revaccination guidelines exist but are debated, particularly for high-risk groups.
  • Concerns persist regarding the safety and adverse reactions associated with PPV revaccination in specific patient populations.

Purpose of the Study:

  • To evaluate the safety profile of pneumococcal polysaccharide revaccination.
  • To determine the incidence and nature of adverse reactions following PPV revaccination.

Main Methods:

  • A prospective study involving 151 patients undergoing pneumococcal polysaccharide revaccination.
  • Data collection via questionnaires assessing adverse reactions within 72 hours post-injection.
  • Analysis of valid data from 127 participants.

Main Results:

  • Mild systemic reactions were reported in 4% to 8% of patients.
  • Local reactions occurred in 40% to 60% of patients.
  • The observed adverse reaction profile was similar to that of initial pneumococcal vaccination.

Conclusions:

  • Pneumococcal polysaccharide revaccination demonstrates an acceptable safety profile.
  • The incidence of adverse reactions is comparable to primary vaccination, alleviating concerns about revaccination safety.

Related Experiment Videos